FDA Approves JUVÉDERM VOLBELLA XC for Undereye Hollows
Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.
Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.
Health Canada's licensing of the PicoPretty Q-Switched ND:YAG Laser expands Canadian providers' access to a multi-mode platform for tattoo removal, pigmentation treatment, skin rejuvenation, vascular applications, and hair reduction.